This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Trinchieri G, Scott P . Interleukin-12: basic principles and clinical applications Curr Top Microbiol Immunol 1999 238: 57–78
Lee SM, Suen Y, Qian J, Knoppel E, Cairo MS . The regulation and biological activity of interleukin 12 Leuk Lymphoma 1998 29: 427–438
Ploemacher RE, van Soest PL, Voorwinden H, Boudewijn A . Interleukin-12 synergizes with interleukin-3 and steel factor to enhance recovery of murine hemopoietic stem cells in liquid culture Leukemia 1993 7: 1381–1388
Bellone G, Trinchieri G . Dual stimulatory and inhibitory effect of NK cell stimulatory factor/IL-12 on human hematopoiesis J Immunol 1994 153: 930–937
Inatomi Y, Toyama K, Clark SC, Shimizu K, Miyauchi J . Combinations of stem cell factor with other hematopoietic growth factors enhance growth and sensitivity to cytosine arabinoside of blast progenitors in acute myelogenous leukemia Cancer Res 1994 54: 445–462
Bruserud Φ, Gjertsen BT, Brustugun OT, Bassøe CF, Nesthus I, Akselsen PE, Bühring HJ, Pawelec G . Effects of interleukin 10 on blast cells derived from patients with acute myelogenous leukemia Leukemia 1995 9: 1910–1920
Löwenberg B, Suciu S, Archimbaud E, Ossenkoppele G, Verhoef GE, Vellenga E, Wijermans P, Berneman Z, Dekker AW, Stryckmans P, Schouten H, Jehn U, Muus P, Sonneveld P, Dardenne M, Zittoun R . Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group Blood 1997 90: 2952–2961
Witz F, Sadoun A, Perrin MC, Berthou C, Briere J, Cahn JY, Lioure B, Witz B, Francois S, Desablens B, Pignon B, Le Prise PY, Audhuy B, Caillot D, Casassus P, Delain M, Christian B, Tellier Z, Polin V, Hurteloup P, Harousseau JL . A placebo-controlled study of recombinant human granulocyte–macrophage colony-stimulating factor administered during and after induction treatment for de novo acute myelogenous leukemia in elderly patients. Groupe Ouest Est Leucemies Aigues Myeloblastiques (GOELAM) Blood 1998 91: 2722–2730
Acknowledgements
The author thanks Dr K Toyama, First Department of Internal Medicine, Tokyo Medical college, for providing patient samples and T Minegishi for assistance in cell culture.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miyauchi, J. In vitro effects of interleukin-12 on the growth of blast progenitors in acute myelogenous leukemia. Leukemia 15, 1996–1998 (2001). https://doi.org/10.1038/sj.leu.2402308
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402308